(Q39445355)

12 September 2017

1 reference

title

Are symptoms the most important target for therapy in chronic heart failure? (English)

1 reference

12 September 2017

0 references

chronic heart failure

1 reference

Cleland JG

1

1 reference

12 September 2017

publication date

1 July 1998

1 reference

Progress in Cardiovascular Diseases

12 September 2017

published in

1 reference

12 September 2017

volume

41

1 reference

12 September 2017

issue

1 Suppl 1

1 reference

12 September 2017

page(s)

59-64

1 reference

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Ventricular dysfunction and the risk of stroke after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Frusemide or nitrates for acute heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Measurement of the quality of life in congestive heart failure--influence of drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Beta-blocking agents in heart failure. Should they be used and how?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Is aspirin safe for patients with heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

Optimising heart failure pharmacotherapy: the ideal combination.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980032-7

7 January 2021

10.1016/S0033-0620(98)80032-7

Identifiers

DOI

1 reference

12 September 2017

1 reference